BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 1990041)

  • 1. Treatment of beta-hemolytic streptococcal pharyngitis with cefaclor or penicillin. Efficacy and interaction with beta-lactamase-producing organisms in the pharynx.
    Reed BD; Huck W; Zazove P
    J Fam Pract; 1991 Feb; 32(2):138-44. PubMed ID: 1990041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overcoming penicillin failures in the treatment of Group A streptococcal pharyngo-tonsillitis.
    Brook I
    Int J Pediatr Otorhinolaryngol; 2007 Oct; 71(10):1501-8. PubMed ID: 17644191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Beta-lactamase producing bacteria in the pharyngeal flora of patients with acute pharyngitis].
    Romero-Vivas J; Betriu C; Sánchez ML; Herranz B; Picazo JJ
    Enferm Infecc Microbiol Clin; 1995 Jan; 13(1):33-9. PubMed ID: 7893790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Significance of normal oropharyngeal flora in the development of streptococcal pharyngitis and outcome of penicillin therapy].
    Mihajlović-Ukropina M; Roncević N
    Med Pregl; 1998; 51(5-6):275-8. PubMed ID: 9720358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the effect of benzathine penicillin G, clarithromycin, cefprozil and amoxicillin/clavulanate on the bacteriological response and throat flora in group A beta hemolytic streptococcal tonsillopharyngitis.
    Yildirim I; Ceyhan M; Gür D; Kaymakoğlu I
    Turk J Pediatr; 2008; 50(2):120-5. PubMed ID: 18664074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cefaclor versus penicillin V in staphylococcal infections in children].
    Cohen R; de La Rocque F; Boucherat M; Lecompte MD; Bouhanna A; Wollner A; Ponet D; Elbez A; Richoux F; Brami A
    Ann Pediatr (Paris); 1991 Apr; 38(4):289-95. PubMed ID: 1906258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of influence of beta-lactamase-producing flora on recovery of group A streptococci after treatment of acute pharyngitis.
    Tanz RR; Shulman ST; Sroka PA; Marubio S; Brook I; Yogev R
    J Pediatr; 1990 Dec; 117(6):859-63. PubMed ID: 2123240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Controversies in the treatment of streptococcal pharyngitis.
    Pichichero ME
    Am Fam Physician; 1990 Dec; 42(6):1567-76. PubMed ID: 2244548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential mechanisms for failure to eradicate group A streptococci from the pharynx.
    Gerber MA; Tanz RR; Kabat W; Bell GL; Siddiqui Bp; Lerer TJ; Lepow ML; Kaplan EL; Shulman ST
    Pediatrics; 1999 Oct; 104(4 Pt 1):911-7. PubMed ID: 10506234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Failure to eradicate streptococci and beta-lactamase producing bacteria.
    Brook I; Gober AE
    Acta Paediatr; 2008 Feb; 97(2):193-5. PubMed ID: 18254908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cefaclor AF in the treatment of streptococcal pharyngitis/tonsillitis.
    Derriennic M; Voi M; Thoren LM; Black SA; Dere WH
    Postgrad Med J; 1992; 68 Suppl 3():S43-6; discussion S46-8. PubMed ID: 1287618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of cefaclor in the treatment of beta-haemolytic streptococcal throat infections in children.
    Disney FA; Breese BB; Francis AB; Green JL; Talpey WB
    Postgrad Med J; 1979; 55 Suppl 4():50-2. PubMed ID: 398481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of bacterial interference and beta-lactamase-producing bacteria in the failure of penicillin to eradicate group A streptococcal pharyngotonsillitis.
    Brook I; Gober AE
    Arch Otolaryngol Head Neck Surg; 1995 Dec; 121(12):1405-9. PubMed ID: 7488371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A pooled comparison of cefdinir and penicillin in the treatment of group a beta-hemolytic streptococcal pharyngotonsillitis.
    Brook I
    Clin Ther; 2005 Aug; 27(8):1266-73. PubMed ID: 16199251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Penicillin failure and copathogenicity in streptococcal pharyngotonsillitis.
    Brook I
    J Fam Pract; 1994 Feb; 38(2):175-9. PubMed ID: 8308510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Defining the optimum treatment regimen for azithromycin in acute tonsillopharyngitis.
    Cohen R
    Pediatr Infect Dis J; 2004 Feb; 23(2 Suppl):S129-34. PubMed ID: 14770076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [5 days Cefaclor vs. 10 days amoxicillin/clavulanate in the treatment of childhood streptococcal pharyngitis. Data from a randomized clinical trial].
    Bottaro G; Biasci P; Lo Giudice M; Mele G; Montanari G; Napoleone E; Santucci A; Tucci PL; Fano M; Biraghi MG
    Minerva Pediatr; 2012 Jun; 64(3):341-6. PubMed ID: 22555328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Symptomatic relapse of group A beta-hemolytic streptococcal tonsillopharyngitis in children.
    Casey JR; Pichichero ME
    Clin Pediatr (Phila); 2007 May; 46(4):307-10. PubMed ID: 17475987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparative study of cefaclor vs. amoxicillin/clavulanate in tonsillopharyngitis.
    Haczyński J; Bardadin J; Gryczyńska D; Gryczyński M; Gołabek W; Kawalski H; Kaźmierczak H; Krecicki T; Kubik P; Namysłowski G; Popiel L
    Med Sci Monit; 2001; 7(5):1016-22. PubMed ID: 11535952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Group A beta-hemolytic streptococcal pharyngitis: current clinical concepts.
    Kiselica D
    Am Fam Physician; 1994 Apr; 49(5):1147-54. PubMed ID: 8154403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.